Form 4 · Filed Jun 4, 2026, 09:54 PM UTC
NBIX/NEUROCRINE BIOSCIENCES INC
Keswani Sanjay Chandru — Chief Medical Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | M | other | 3,212 | $0 | — | 3,212 |
| Jun 2, 2026 | F | other | 1,733 | $155 | $268,338 | 1,479 |
| Jun 2, 2026 | M | other | 3,212 | — | — | 9,634 |
Source: SEC EDGAR raw filing ↗ · Accession 0001818524-26-000004